306 related articles for article (PubMed ID: 32728023)
1. Microbiome harbored within tumors: a new chance to revisit our understanding of cancer pathogenesis and treatment.
Zhao K; Hu Y
Signal Transduct Target Ther; 2020 Jul; 5(1):136. PubMed ID: 32728023
[No Abstract] [Full Text] [Related]
2. The microbiome and transfusion in cancer patients.
Goubran H; Seghatchian J; Radosevic J; Ragab G; Burnouf T
Transfus Apher Sci; 2017 Jun; 56(3):330-335. PubMed ID: 28633955
[TBL] [Abstract][Full Text] [Related]
3. The human tumor microbiome is composed of tumor type-specific intracellular bacteria.
Nejman D; Livyatan I; Fuks G; Gavert N; Zwang Y; Geller LT; Rotter-Maskowitz A; Weiser R; Mallel G; Gigi E; Meltser A; Douglas GM; Kamer I; Gopalakrishnan V; Dadosh T; Levin-Zaidman S; Avnet S; Atlan T; Cooper ZA; Arora R; Cogdill AP; Khan MAW; Ologun G; Bussi Y; Weinberger A; Lotan-Pompan M; Golani O; Perry G; Rokah M; Bahar-Shany K; Rozeman EA; Blank CU; Ronai A; Shaoul R; Amit A; Dorfman T; Kremer R; Cohen ZR; Harnof S; Siegal T; Yehuda-Shnaidman E; Gal-Yam EN; Shapira H; Baldini N; Langille MGI; Ben-Nun A; Kaufman B; Nissan A; Golan T; Dadiani M; Levanon K; Bar J; Yust-Katz S; Barshack I; Peeper DS; Raz DJ; Segal E; Wargo JA; Sandbank J; Shental N; Straussman R
Science; 2020 May; 368(6494):973-980. PubMed ID: 32467386
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome and Obesity. How to Prove Causality?
Gérard P
Ann Am Thorac Soc; 2017 Nov; 14(Supplement_5):S354-S356. PubMed ID: 29161082
[TBL] [Abstract][Full Text] [Related]
5. Metabolite and Microbiome Interplay in Cancer Immunotherapy.
Johnson CH; Spilker ME; Goetz L; Peterson SN; Siuzdak G
Cancer Res; 2016 Nov; 76(21):6146-6152. PubMed ID: 27729325
[TBL] [Abstract][Full Text] [Related]
6. The microbiome and cancer for clinicians.
Picardo SL; Coburn B; Hansen AR
Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
[TBL] [Abstract][Full Text] [Related]
7. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology intervention of the microbiome for cancer therapy.
Song W; Anselmo AC; Huang L
Nat Nanotechnol; 2019 Dec; 14(12):1093-1103. PubMed ID: 31802032
[TBL] [Abstract][Full Text] [Related]
9. Microbiome and cancer immunotherapy.
Chilakapati SR; Ricciuti J; Zsiros E
Curr Opin Biotechnol; 2020 Oct; 65():114-117. PubMed ID: 32192986
[TBL] [Abstract][Full Text] [Related]
10. Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents.
Walter J; Armet AM; Finlay BB; Shanahan F
Cell; 2020 Jan; 180(2):221-232. PubMed ID: 31978342
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human tumor microbiome reveals tumor-type specific intra-cellular bacteria.
Livyatan I; Nejman D; Shental N; Straussman R
Oncoimmunology; 2020 Jul; 9(1):1800957. PubMed ID: 32934891
[TBL] [Abstract][Full Text] [Related]
12. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
Gately S
Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
[TBL] [Abstract][Full Text] [Related]
13. Microbiota in cancer development and treatment.
Raza MH; Gul K; Arshad A; Riaz N; Waheed U; Rauf A; Aldakheel F; Alduraywish S; Rehman MU; Abdullah M; Arshad M
J Cancer Res Clin Oncol; 2019 Jan; 145(1):49-63. PubMed ID: 30542789
[TBL] [Abstract][Full Text] [Related]
14. Microbiota: a key orchestrator of cancer therapy.
Roy S; Trinchieri G
Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904
[TBL] [Abstract][Full Text] [Related]
15. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy.
Joukar F; Mavaddati S; Mansour-Ghanaei F; Samadani AA
J Gastrointest Cancer; 2020 Jun; 51(2):363-378. PubMed ID: 31025167
[TBL] [Abstract][Full Text] [Related]
17. Roles of intestinal microbiota in response to cancer immunotherapy.
Cong J; Zhang X
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2235-2240. PubMed ID: 30209679
[TBL] [Abstract][Full Text] [Related]
18. The human microbiome in health and disease: hype or hope.
Falony G; Vandeputte D; Caenepeel C; Vieira-Silva S; Daryoush T; Vermeire S; Raes J
Acta Clin Belg; 2019 Apr; 74(2):53-64. PubMed ID: 30810508
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil induced dysregulation of the microbiome-gut-brain axis manifesting as depressive like behaviors in rats.
Zhang F; Chen H; Zhang R; Liu Y; Kong N; Guo Y; Xu M
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165884. PubMed ID: 32574836
[TBL] [Abstract][Full Text] [Related]
20. The microbiome in anti-cancer therapy.
Bashiardes S; Tuganbaev T; Federici S; Elinav E
Semin Immunol; 2017 Aug; 32():74-81. PubMed ID: 28431920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
